Multimodal intervention based on physical exercise, mindfulness, behaviour change and education to improve pain and health in patients with chronic primary low back pain: a study protocol of the HEALTHYBACK randomised controlled trial
Metadatos
Mostrar el registro completo del ítemAutor
Tsiarleston, Gavriella; López-Fernández, Maria Dolores; Pavón Muñoz, Rodrigo; Aguilera García, Iván; López Corchón, María; Delgado Fernández, Manuel; Castellote Caballero, Yolanda; Donoso, Belén; Mesa Ruiz, Antonio Manuel; Pozuelo Calvo, Rocio; Ríos Ortiz, Ángela María; Álvarez Corral, Gemma; Marín Jiménez, Nuria; Martínez García, Dario; Chirosa Ríos, Ignacio Jesús; Segura Jiménez, VíctorEditorial
BMJ Publishing Group
Fecha
2024-11-21Referencia bibliográfica
Tsiarleston, G. et. al. BMJ Open Sport & Exercise Medicine 2024;10:e002188. [https://doi.org/10.1136/bmjsem-2024-002188]
Patrocinador
Instituto de Salud Carlos III through the fellowships CP20/00178 and PI22/01791, co-funded by the European Social Fund; Instituto de Salud Carlos III through the PFIS contract (FI23/00034), co-funded by the European Social Fund+; 'Margarita Salas' postdoctoral grant UCOR01MS, convened by the University of Córdoba (UCO) and funded by the Ministry of the University of Spain and the European Union-Next Generation EUResumen
The HEALTHYBACK trial is based on a multimodal
intervention to determine the effectiveness of a supervised
physical exercise, mindfulness, behaviour change and
pain neuroscience education programme on several health
variables in individuals with chronic primary low back pain
(CPLBP). The study will be a randomised controlled trial
among 70 individuals diagnosed with CPLBP (aged 18–65
years). The intervention will be conducted in person within
a hospital setting for 16 weeks and comprises a first phase
(16 sessions supervised physical exercise (2 days/week,
45 min/session), mindfulness (1 day/week, 2.5 hours/
session), behaviour change (daily/24 hours via a wrist-worn
activity prompting device) and pain neuroscience
education (1 day/biweekly, 2 hours/session)) and a
second phase (16 sessions functional full-body
muscle
strengthening exercise, 3 days/week, 50 min/session). The
primary outcomes will include perceived acute pain, pain
pressure threshold, conditioned pain modulation, temporal
summation of pain and disability due to pain. Secondary
measures will include physical fitness, body composition,
gait parameters, device-measured
physical activity and
sedentary behaviour, haematological profile, self-reported
sedentary behaviour, quality of life, pain catastrophising,
mental health, sleep duration and quality, and symptoms
related to central sensitisation. The groups will undergo
pretest (before the intervention), post-test
(after each phase
of the intervention) and retest (at a 6-week
detraining
period after the intervention) measurements. The results
will determine the effectiveness of multidimensional
interventions on several health parameters in individuals
with CPLBP. They will provide knowledge for pain
management and functioning in affected individuals, which
might diminish the need for primary healthcare services.
Trial registration number: NCT06114264.





